Evidence map›Paper›PMID 28598034›Full record

ArticleZoonoses and public health2018

Hepatitis E in southern Vietnam: Seroepidemiology in humans and molecular epidemiology in pigs.

A Berto, H A Pham, T T N Thao, N H T Vy, S L Caddy, R Hiraide, N T Tue, I Goodfellow, J J Carrique-Mas, G E Thwaites and 3 more

Open access · hybridAbstract read
In one paragraph

Article in Zoonoses and public health, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed, 5 pooled it
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 5 syntheses or guidelines pooled it, 37 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 4 institutions in 6 countries.

A BertoWellcome Trust Major Overseas Programme, Oxford University Clinical Research Unit, Ho Chi Minh City, Vietnam.ORCID 0000-0003-4005-9464
H A PhamWellcome Trust Major Overseas Programme, Oxford University Clinical Research Unit, Ho Chi Minh City, Vietnam.ORCID 0000-0001-9668-9233
T T N ThaoWellcome Trust Major Overseas Programme, Oxford University Clinical Research Unit, Ho Chi Minh City, Vietnam.
N H T VyWellcome Trust Major Overseas Programme, Oxford University Clinical Research Unit, Ho Chi Minh City, Vietnam.
S L CaddyUK Division of Virology, Department of Pathology, University of Cambridge, Cambridge, UK.
R HiraideUK Division of Virology, Department of Pathology, University of Cambridge, Cambridge, UK.
N T TueWellcome Trust Major Overseas Programme, Oxford University Clinical Research Unit, Ho Chi Minh City, Vietnam.
I GoodfellowUK Division of Virology, Department of Pathology, University of Cambridge, Cambridge, UK.
J J Carrique-MasWellcome Trust Major Overseas Programme, Oxford University Clinical Research Unit, Ho Chi Minh City, Vietnam.
G E ThwaitesWellcome Trust Major Overseas Programme, Oxford University Clinical Research Unit, Ho Chi Minh City, Vietnam.
S BakerWellcome Trust Major Overseas Programme, Oxford University Clinical Research Unit, Ho Chi Minh City, Vietnam.
M F BoniWellcome Trust Major Overseas Programme, Oxford University Clinical Research Unit, Ho Chi Minh City, Vietnam.
VIZIONS consortium
Oxford University Clinical Research Unit · VNUniversity of Cambridge · GBAngkor Hospital for Children · KHPennsylvania State University · US

Funding

Medical Research Council MC_UU_12014/12Wellcome Trust 093724Wellcome Trust 097997Wellcome Trust 097997/Z/11/ZWellcome Trust 098511Wellcome Trust 098511/Z/12/ZWellcome Trust 100087Wellcome Trust 100087/Z/12/ZWellcome Trust WT/093724
6 · The paper itself

Abstract

Viral pathogens account for a significant proportion of the burden of emerging infectious diseases in humans. The Wellcome Trust-Vietnamese Initiative on Zoonotic Infections (WT-VIZIONS) is aiming to understand the circulation of viral zoonotic pathogens in animals that pose a potential risk to human health. Evidence suggests that human exposure and infections with hepatitis E virus (HEV) genotypes (GT) 3 and 4 results from zoonotic transmission. Hypothesising that HEV GT3 and GT4 are circulating in the Vietnamese pig population and can be transmitted to humans, we aimed to estimate the seroprevalence of HEV exposure in a population of farmers and the general population. We additionally performed sequence analysis of HEV in pig populations in the same region to address knowledge gaps regarding HEV circulation and to evaluate if pigs were a potential source of HEV exposure. We found a high prevalence of HEV GT3 viral RNA in pigs (19.1% in faecal samples and 8.2% in rectal swabs) and a high HEV seroprevalence in pig farmers (16.0%) and a hospital-attending population (31.7%) in southern Vietnam. The hospital population was recruited as a general-population proxy even though this particular population subgroup may introduce bias. The detection of HEV RNA in pigs indicates that HEV may be a zoonotic disease risk in this location, although a larger sample size is required to infer an association between HEV positivity in pigs and seroprevalence in humans.

Indexed as

Molecular EpidemiologyAnimalsFarmersHepatitis EHepatitis E virusHumansRNA, ViralSeroepidemiologic StudiesSwineSwine DiseasesVietnamZoonosesRNA, Viralhepatitis E virushumanpigsprevalenceseroprevalenceVietnamzoonosis

Identifiers

PMID28598034
PMCPMC6645987
OpenAlexW2623983380

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.